Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Case Rep Obstet Gynecol ; 2018: 6930986, 2018.
Article in English | MEDLINE | ID: mdl-30627463

ABSTRACT

A 68-year-old woman presented with a three-week history of confusion and anomic aphasia. Imaging of her head demonstrated a single large left frontal mass. Pathology revealed metastatic adenocarcinoma of Müllerian origin. Subsequent surgery revealed a small primary site in a fallopian tube, high left para-aortic lymphadenopathy, and no disseminated intraperitoneal disease. This case was remarkable in that CNS metastasis was her presenting symptom and was restricted to a solitary brain lesion, and other disease sites were limited to retroperitoneal lymphadenopathy and a small fallopian tube primary.

2.
Gynecol Oncol ; 143(3): 521-525, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27693123

ABSTRACT

OBJECTIVE: To quantify the impact of perioperative ß blocker use on survival after primary cytoreductive surgery for epithelial ovarian cancer. METHODS: We conducted a multi-center retrospective study of all women who underwent primary cytoreductive surgery for ovarian cancer (2000-2010). One institution had routinely used perioperative ß blockers for patients "at risk" for coronary events. The other institution did not routinely use perioperative ß blockers. Demographic, operative, and follow up data were collected. Cox proportional hazards models were used to assess the effect of ß blockers on progression-free interval (PFI) as well as overall survival (OS). RESULTS: Out of 185 eligible patients, 70 received ß blockers and 115 underwent cytoreductive surgery without perioperative ß blockers. Both groups were similar in demographics. A history of hypertension was present more often in the ß blocker group compared to the group that did not receive ß blockers (22% and 6%, p=0.002). PFI in ß blocker group was greater at 18.2 vs. 15.8months (p=0.66). The OS in the ß blocker group was significantly higher at 44.2 vs. 39.3months (p=0.01). In multivariate analysis, perioperative ß blocker use was associated with significant improvement in OS (HR 0.68 (0.46-0.99); p=0.046). CONCLUSION: Our study showed an association between perioperative ß blocker use and longer overall survival in patients undergoing primary ovarian cancer cytoreductive surgery. A prospective randomized clinical trial in this population would further validate these results.


Subject(s)
Adenocarcinoma, Clear Cell/surgery , Adrenergic beta-Antagonists/therapeutic use , Carcinoma, Endometrioid/surgery , Cytoreduction Surgical Procedures/methods , Neoplasms, Cystic, Mucinous, and Serous/surgery , Neoplasms, Glandular and Epithelial/surgery , Ovarian Neoplasms/surgery , Perioperative Care/methods , Adenocarcinoma, Clear Cell/epidemiology , Adenocarcinoma, Clear Cell/pathology , Aged , Carcinoma, Endometrioid/epidemiology , Carcinoma, Endometrioid/pathology , Carcinoma, Ovarian Epithelial , Case-Control Studies , Comorbidity , Disease-Free Survival , Female , Humans , Hypertension/epidemiology , Middle Aged , Multivariate Analysis , Neoplasm Grading , Neoplasms, Cystic, Mucinous, and Serous/epidemiology , Neoplasms, Cystic, Mucinous, and Serous/pathology , Neoplasms, Glandular and Epithelial/epidemiology , Neoplasms, Glandular and Epithelial/pathology , Ovarian Neoplasms/epidemiology , Ovarian Neoplasms/pathology , Proportional Hazards Models , Retrospective Studies , Survival Rate , Treatment Outcome
3.
Contraception ; 81(5): 446-51, 2010 May.
Article in English | MEDLINE | ID: mdl-20399953

ABSTRACT

BACKGROUND: Despite the availability of first trimester abortion services in urban settings, many women request abortion in the second trimester. We identified protective and risk factors associated with women who delay requesting abortions until the second trimester. STUDY DESIGN: The study was a cross-sectional survey of 247 patients requesting surgical abortion at an urban family planning clinic. Survey and medical records data were analyzed for associations between 18 risk factors and incidence of second trimester request. RESULTS: Thirty-two percent of subjects presented in the second trimester. Chi-square analyses revealed that first trimester participants were more often employed (p<.0001), privately insured (p=.01), or had previous abortions (p=.04). Second trimester patients were younger (p<.0001), more often primigravid (p=.04), experienced more difficulty financing the procedure (p<.0001) and finding a surgeon (p<.0001), traveled longer distances (p=.005), and more often feared the procedure (p=.03). Using multiple logistic regression, women requesting second trimester abortions were more likely to report: obstacles financing the abortion (OR 2.34, 95% CI 1.28-4.28); traveling long distances (OR 2.88, 95% CI 1.31-6.31); and fear (OR 2.45, 95% CI 1.17-5.17). These women were less often employed outside the home (OR 0.35, 95% CI 0.19-0.64). CONCLUSIONS: Physicians and advocates must strive to reduce abortion costs, increase access to trained surgeons, and allay women's fears of abortion procedures.


Subject(s)
Abortion, Induced , Patient Acceptance of Health Care , Pregnancy Trimester, First , Pregnancy Trimester, Second , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Pregnancy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...